Boston Scientific | BSX - Trade Debtors


Boston Scientific reported $2.93B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Abbott USD 11.22B 655M Mar/2026
AtriCure USD 79.98M 8.67M Jun/2026
Avanos Medical USD 103M 800K Mar/2026
Baxter International USD 1.7B 310M Mar/2026
Becton, Dickinson and Co. USD 2.2B 303M Mar/2026
Boston Scientific USD 2.93B 98M Dec/2025
CONMED USD 247.83M 22.89M Dec/2025
Cooper Companies USD 809.2M 2.1M Mar/2026
Danaher USD 4.96B 205M Jun/2026
Dexcom USD 1.09B 182.1M Mar/2026
Edwards Lifesciences USD 973M 60.9M Mar/2026
Globus Medical USD 735.44M 8.23M Mar/2026
Illumina USD 738M 116M Mar/2026
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 544.7M 27.8M Mar/2026
Integra LifeSciences USD 264.41M 14.44M Mar/2026
Intuitive Surgical USD 1.67B 77.6M Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Medtronic USD 6.36B 30M Dec/2025
Merit Medical Systems USD 227M 3.39M Mar/2026
Stryker USD 3.57B 468M Mar/2026
Tandem Diabetes Care USD 165.49M 39.55M Dec/2025
Teleflex USD 365.53M 19.94M Mar/2026
Zimmer Biomet Holdings USD 1.73B 24.2M Mar/2026